Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Non-cash Items for 7 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 94.37% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, down 94.37% year-over-year, with the annual reading at $5.1 million for FY2025, 94.37% down from the prior year.
  • Non-cash Items hit $5.1 million in Q4 2025 for IDEAYA Biosciences, up from $4.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $115.7 million in Q1 2025 to a low of $41400.0 in Q4 2021.
  • Historically, Non-cash Items has averaged $33.0 million across 5 years, with a median of $28.0 million in 2022.
  • Biggest five-year swings in Non-cash Items: soared 67532.85% in 2022 and later crashed 94.37% in 2025.
  • Year by year, Non-cash Items stood at $41400.0 in 2021, then skyrocketed by 67532.85% to $28.0 million in 2022, then surged by 46.79% to $41.1 million in 2023, then surged by 119.46% to $90.2 million in 2024, then plummeted by 94.37% to $5.1 million in 2025.
  • Business Quant data shows Non-cash Items for IDYA at $5.1 million in Q4 2025, $4.8 million in Q3 2025, and $4.4 million in Q2 2025.